Atrion Corporation

644.00+2.11+0.33%Vol 2.36K1Y Perf -10.15%
Apr 9th, 2021 16:00 DELAYED
BID636.01 ASK0.0000
Open645.34 Previous Close641.89
Pre-Market- After-Market-
 - -  - -%
Target Price
300.00 
Analyst Rating
— 0.00
Potential %
-53.42 
Finscreener Ranking
★★★★★     60.16
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     62.31
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     63.30
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★+     49.10
Market Cap1.18B 
Earnings Rating
Buy
Price Range Ratio 52W %
43.26 
Earnings Date
6th May 2021

Today's Price Range

639.63645.34

52W Range

567.00745.00

5 Year PE Ratio Range

22.6051.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.09%
1 Month
-0.98%
3 Months
-3.38%
6 Months
0.87%
1 Year
-10.15%
3 Years
7.15%
5 Years
62.73%
10 Years
294.04%

TickerPriceChg.Chg.%
ATRI644.002.11000.33
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
ProfitabilityValueIndustryS&P 500US Markets
44.80
24.20
32.10
27.30
22.42
RevenueValueIndustryS&P 500US Markets
104.00M
56.97
0.19
1.17
DividendsValueIndustryS&P 500US Markets
1.08
7.00
13.63
14.64
Payout ratio32.00
Earnings HistoryEstimateReportedSurprise %
Q03 2020-3.95-
Q02 2020-4.68-
Q01 2020-4.79-
Q04 2019-4.33-
Q03 2019-5.15-
Q02 2019-5.18-
Q01 2019-5.07-
Q04 2018-4.17-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.36K
Shares Outstanding1.83M
Trades Count261
Dollar Volume5.64M
Avg. Volume8.44K
Avg. Weekly Volume2.25K
Avg. Monthly Volume7.46K
Avg. Quarterly Volume8.39K

Atrion Corporation (NASDAQ: ATRI) stock closed at 644 per share at the end of the most recent trading day (a 0.33% change compared to the prior day closing price) with a volume of 2.36K shares and market capitalization of 1.18B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 616 people. Atrion Corporation CEO is David A. Battat.

The one-year performance of Atrion Corporation stock is -10.15%, while year-to-date (YTD) performance is 0.27%. ATRI stock has a five-year performance of 62.73%. Its 52-week range is between 567 and 745, which gives ATRI stock a 52-week price range ratio of 43.26%

Atrion Corporation currently has a PE ratio of 36.90, a price-to-book (PB) ratio of 4.87, a price-to-sale (PS) ratio of 11.39, a price to cashflow ratio of 30.10, a PEG ratio of 2.32, a ROA of 11.63%, a ROC of 13.32% and a ROE of 12.86%. The company’s profit margin is 22.42%, its EBITDA margin is 32.10%, and its revenue ttm is $104.00 Million , which makes it $56.97 revenue per share.

Of the last four earnings reports from Atrion Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Atrion Corporation’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Atrion Corporation is (0), with a target price of $300, which is -53.42% compared to the current price. The earnings rating for Atrion Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Atrion Corporation has a dividend yield of 1.08% with a dividend per share of $7.00 and a payout ratio of 32.00%.

Atrion Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.06, ATR14 : 23.88, CCI20 : -20.37, Chaikin Money Flow : 148.24, MACD : -9.88, Money Flow Index : 44.88, ROC : 3.74, RSI : 49.45, STOCH (14,3) : 70.82, STOCH RSI : 1.00, UO : 50.62, Williams %R : -29.18), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Atrion Corporation in the last 12-months were: David A. Battat (Option Excercise at a value of $3 228 000), Emile A. Battat (Option Excercise at a value of $2 784 300)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
1 (100.00 %)
Summary Rating--Strong Sell
5.00

Atrion Corporation

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

CEO: David A. Battat

Telephone: +1 972 390-9800

Address: One Allentown Parkway, Allen 75002, TX, US

Number of employees: 616

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

59%41%

Bearish Bullish

49%51%

News

Stocktwits